Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction of Tegoprazan with Metronidazole, Tetracycline, and Bismuth
NCT04066257Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- Jan 2019
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tegoprazan in Helicobacter pylori infection (3 arms), sponsored by HK inno.N Corporation. Primary endpoints: Area Under the Curve from time 0 to 12 hours, Maximum Plasma Concentration at Day 7 and 1 more. Started Jan 2019; status: completed.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04066257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066257.